Uno, Tsukasa <br/><br/>
Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.  [electronic resource] 

 -  British journal of clinical pharmacology  Mar 2006 
 - 309-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0306-5251 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2125.2005.02556.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles<br/>Administration, Oral<br/>Adult<br/>Area Under Curve<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Benzimidazoles--blood<br/>Cross-Over Studies<br/>Cytochrome P-450 CYP2C19<br/>Double-Blind Method<br/>Enzyme Inhibitors--blood<br/>Female<br/>Fluvoxamine--administration & dosage<br/>Heterozygote<br/>Homozygote<br/>Humans<br/>Male<br/>Mixed Function Oxygenases--genetics<br/>Omeprazole--analogs & derivatives<br/>Rabeprazole<br/>Selective Serotonin Reuptake Inhibitors--administration & dosage